Wong Kelvin, Kim Dae Hyeon, Iakovou Annamaria, Khanijo Sameer, Tsegaye Adey, Hahn Stella, Narasimhan Mangala, Zaidi Gulrukh
Pulmonary and Critical Care Medicine, Northwell Health North Shore University Hospital, Manhasset, USA.
Pulmonary and Critical Care Medicine, Long Island Jewish Medical Center, Manhasset, USA.
Cureus. 2020 Nov 28;12(11):e11749. doi: 10.7759/cureus.11749.
Objective The study aims to describe the clinical characteristics and outcomes of patients with COVID-19 related acute respiratory distress syndrome (ARDS) who developed pneumothorax. Design and setting A retrospective chart review was performed of the electronic medical record. Patients were included if they were identified as having confirmed COVID-19 as well as pneumothorax from March 16, 2020 to May 31, 2020. Patients' demographic and clinical characteristics, mechanical ventilator parameters, lung compliance measurements and outcomes during hospitalization were collected. This case series was conducted in intensive care units at two large tertiary care centers within the Northwell Health System, located in New York State. Patients A total of 75 patients were identified who were predominantly male (73.3%) with an average age of 62.8 years. Thirty (40%) were Hispanic, 20 (26.7%) were White, 16 (21.3%) were Asian, and nine (12%) were Black. Common comorbid conditions were hypertension (52%), diabetes mellitus (26.7%), hyperlipidemia (32.0%), and chronic pulmonary disease (8, 10.7%). Measurements and main results Most of the patients were diagnosed with pneumothorax while on mechanical ventilation (92%) despite overall adherence with lung-protective ventilation strategies. Average tidal volume was 6.66 mL/kg) of ideal body weight. The average positive end-expiratory pressure (PEEP) was 10.83 (cm) H2O. Lung compliance was poor, with average peak and plateau pressures of 41.9 cm H2O and 35.2 cm H2O, respectively. Inpatient mortality was high in these patients (76%). Conservative management with initial observation had a success rate (73.3%) with similar mortality and shorter length of stay (LOS) on average. Significant factors in the conservatively managed group included lack of tension physiology, the smaller size of pneumothorax, lack of underlying diabetes, presence of pneumomediastinum, and not being on mechanical ventilation during diagnosis. Conclusion Despite overall adherence to best practice ventilator management in ARDS, we observed a large number of pneumothoraces during the COVID-19 pandemic. Conservative management may be appropriate if there are no clinical signs or symptoms of tension physiology and pneumothorax size is small.
目的 本研究旨在描述新型冠状病毒肺炎(COVID-19)相关急性呼吸窘迫综合征(ARDS)并发气胸患者的临床特征及预后。
设计与背景 对电子病历进行回顾性图表审查。纳入2020年3月16日至2020年5月31日期间确诊为COVID-19且并发气胸的患者。收集患者的人口统计学和临床特征、机械通气参数、肺顺应性测量值及住院期间的预后情况。本病例系列研究在纽约州诺斯韦尔医疗系统内的两家大型三级医疗中心的重症监护病房进行。
患者 共识别出75例患者,其中男性占主导(73.3%),平均年龄62.8岁。30例(40%)为西班牙裔,20例(26.7%)为白人,16例(21.3%)为亚洲人,9例(12%)为黑人。常见合并症包括高血压(52%)、糖尿病(26.7%)、高脂血症(32.0%)和慢性肺部疾病(8例,10.7%)。
测量指标及主要结果 尽管总体上遵循肺保护性通气策略,但大多数患者(92%)在机械通气期间被诊断为气胸。平均潮气量为理想体重的6.66 mL/kg。平均呼气末正压(PEEP)为10.83 cmH₂O。肺顺应性较差,平均峰压和平台压分别为41.9 cmH₂O和35.2 cmH₂O。这些患者的住院死亡率较高(76%)。初始观察的保守治疗成功率为73.3%,死亡率相似,平均住院时间较短。保守治疗组的显著因素包括无张力性气胸表现、气胸体积较小、无潜在糖尿病、存在纵隔气肿以及诊断时未进行机械通气。
结论 尽管在ARDS中总体上遵循最佳实践通气管理,但我们在COVID-19大流行期间观察到大量气胸病例。如果没有张力性气胸的临床体征或症状且气胸体积较小,保守治疗可能是合适的。